首页> 外国专利> NOVEL COMPOSITIONS AND METHODS FOR TREATMENT OF PRIMARY AND METASTATIC CANCERS AND PRECANCEROUS CONDITIONS BY LOCAL AND OR SYSTEMIC INJECTIONS OF A MIXTURE OF ANTI- CANCER TRANSGENIC MESENCHYMAL STEM CELLS OR OTHER SOMATIC CELLS EXPRESSING SPECIFIC TRANSGENES ALONE OR IN COMBINATIONS OF TWO OR MORE THERAPEUTIC PROTEINS.

NOVEL COMPOSITIONS AND METHODS FOR TREATMENT OF PRIMARY AND METASTATIC CANCERS AND PRECANCEROUS CONDITIONS BY LOCAL AND OR SYSTEMIC INJECTIONS OF A MIXTURE OF ANTI- CANCER TRANSGENIC MESENCHYMAL STEM CELLS OR OTHER SOMATIC CELLS EXPRESSING SPECIFIC TRANSGENES ALONE OR IN COMBINATIONS OF TWO OR MORE THERAPEUTIC PROTEINS.

机译:通过局部或全身注射混合表达单个或多种基因突变的原癌基因的原癌转基因间充质干细胞或其他体细胞的局部和/或全身注射,治疗原发和转移性癌症及癌前状况的新型组合物和方法。

摘要

Disclosed are the methods and compositions relating to creating clinically safe genetically modified mesenchymal stem cells derived from umbilical cord tissue/ Wharton™s jelly and or other sources including bone marrow, and cord blood, or creating clinically safe genetically modified somatic cells like lymphocytes enabled with anticancer factors expressed in the background of genetic safety switch such that the in-vivo administered cells can be eliminated at any time desired, along with elimination of adjacent cancer cells such, leading to therapeutic efficacy against cancer and other illnesses.
机译:公开了与创建源自脐带组织/沃顿氏胶冻或其他来源(包括骨髓和脐带血)的临床安全的基因修饰的间充质干细胞,或产生临床安全的基因修饰的体细胞如淋巴细胞结合的方法和组合物。在基因安全性转换背景中表达的抗癌因子,使得可以在任何需要的时间消除体内施用的细胞,同时消除邻近的癌细胞,从而导致针对癌症和其他疾病的治疗功效。

著录项

  • 公开/公告号IN2015MU03161A

    专利类型

  • 公开/公告日2018-01-05

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN3161/MUM/2015

  • 发明设计人 ARATI INAMDAR;AJINKYA INAMDAR;

    申请日2015-08-19

  • 分类号A61K31;

  • 国家 IN

  • 入库时间 2022-08-21 12:52:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号